News

Asieris completed enrollment for its China Phase II Trial of APL-1202

Asieris won a Small to Medium-Size Technological Enterprise (SME) in Jiangsu

Dr. Kevin Pan was selected as a member of “113 Talent Program”

Dr. Yuh visited Nanjing iDatastat, the CRO for APL-1202’s China phase II trial

Asieris initiated TV interview for APL-1202 China phase 2 clinical trial

Asieris held an investigators’ meeting for APL-1202’s phase II clinical trial in China

Asieris achieved objectives in the grant of Supporting Science and Technology

Asieris presented at the fourth China (Taizhou) International Medical Expo

September 2012: Jiangsu FDA inspected APL-1202’s CRO

Asieris Pharmaceuticals establish collabration with US Chinese Anti-cancer Association